Pro: The Role of Albumin in Pre–Liver Transplant Management
Mauro Bernardi, Giacomo Zaccherini, Paolo Caraceni – 22 October 2018 – The wait‐list mortality of patients with decompensated cirrhosis awaiting liver transplantation remains elevated due to the occurrence of complications. Etiologic treatments improve patient survival and lower the incidence of complications when applied in compensated cirrhosis, but a decompensated disease does not improve or even progress despite a response to therapy in a substantial number of patients. Thus, disease‐modifying treatments that reduce the incidence of complications and improve survival are most needed.